missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human VLK Synthetic Peptide
Synthetic Peptide
Brand: Invitrogen™ PEP0989
This item is not returnable.
View return policy
Description
VLK Synthetic Peptide, PEP-0989, from Invitrogen.
VLK was identified as a novel protein kinase that was induced after the differentiation of cultured embryonic stem cells into mesendoderm. It has no homologs in invertebrates, but is highly conserved in vertebrate species although it does not belong to any known protein kinase groups. VLK is initially expressed in E-cadherin-positive anterior visceral endoderm and mesendoderm, but its expression is later confined to E-cadherin-negative mesenchyme. It is enriched in the Golgi apparatus and is thought to regulate the rate of protein export from the Golgi. Targeted disruption of VLK in mice leads to a defect in lung development and neonatal lethality. It has been suggested that mutations in VLK may be associated with the allergic condition atopy.
Specifications
| 91461 | |
| purified | |
| Human VLK | |
| -20°C | |
| Liquid | |
| Blocking Assay, Control | |
| No | |
| Peptide | |
| RUO - research use only |
| Human | |
| Q504Y2 | |
| 200 μg/mL | |
| Synthetic Peptide | |
| PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 | |
| PKDCC | |
| 0.02% sodium azide | |
| 50 μg | |
| PBS |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Invitrogen™ Human VLK Synthetic Peptide > 50 μg; Unlabeled
Spot an opportunity for improvement?Share a Content Correction
